Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells

Oncogene volume 25, pages 4501–4504 (2006)Cite this article

Abstract

The mouse parathyroid hormone-like hormone (Pthlh) gene encodes three allelic variants characterized by amino acid substitutions that are associated with susceptibility (PthlhPro) or resistance (PthlhThr and PthlhSerAspTyr) to two-stage skin carcinogenesis and to modulation of cell migration in vitro in transfected human cancer cells. cDNA microarray hybridization analysis of 8473 transcript clones revealed a similar gene expression profile for the PthlhThr and PthlhSerAspTyr alleles but a distinct pattern for the PthlhPro allele, suggesting an association between a specific gene expression profile and biological function of the Pthlh alleles. Some of the genes modulated by the Pthlh alleles, e.g., ANXA1, CCL2, FN1 and TFF3, play a role in cell migration and may represent candidate targets for this Pthlh function. Our study demonstrates the potential usefulness of gene expression profiling of genetic variants for the functional characterization of candidate cancer modifier genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Benelli R, Peissel B, Manenti G, Gariboldi M, Vanzetto C, Albini A et al. (2003). Oncogene 22: 7711–7715.

  • Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A . (2001). Blood 97: 359–366.

  • De Cecco L, Marchionni L, Gariboldi M, Reid JF, Lagonigro MS, Caramuta S et al. (2004). Oncogene 23: 8171–8183.

  • Deans C, Wigmore S, Paterson-Brown S, Black J, Ross J, Fearon KC . (2005). Cancer 103: 1810–1818.

  • Dragani TA . (2003). Cancer Res 63: 3011–3018.

  • Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ et al. (2005). Ann Surg 241: 491–496.

  • Dysvik B, Jonassen I . (2001). Bioinformatics 17: 369–370.

  • Funk JL . (2001). Int J Immunopharmaco 1: 1101–1121.

  • Hiraki A, Ueoka H, Bessho A, Segawa Y, Takigawa N, Kiura K et al. (2002). Cancer 95: 1706–1713.

  • Hoffmann W, Jagla W, Wiede A . (2001). Histol Histopathol 16: 319–334.

  • Leeb SN, Vogl D, Grossmann J, Falk W, Scholmerich J, Rogler G et al. (2004). Am J Gastroenterol 99: 335–340.

  • Manenti G, Peissel B, Gariboldi M, Falvella FS, Zaffaroni D, Allaria B et al. (2000). Oncogene 19: 5324–5328.

  • Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS et al. (2003). J Immunol 170: 3273–3278.

  • Nagase H, Mao JH, de Koning JP, Minami T, Balmain A . (2001). Cancer Res 61: 1305–1308.

  • Oertel M, Graness A, Thim L, Buhling F, Kalbacher H, Hoffmann W . (2001). Am J RespCell Mol 25: 418–424.

  • Parente L, Solito E . (2004). Inflamm Res 53: 125–132.

  • Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al. (2000). Nat Genet 24: 227–235.

  • Strewler GJ . (2000). N Engl J Med 342: 177–185.

  • Yio X, Zhang JY, Babyatsky M, Chen A, Lin J, Fan QX et al. (2005). Clin Exp Metastasis 22: 157–165.

  • Zhang ZW, Newcomb PV, Moorghen M, Gupta J, Feakins R, Savage P et al. (2004). Cancer Causes Control 15: 211–218.

Download references

Acknowledgements

This work was funded in part by Grants from Associazione and Fondazione Italiana Ricerca Cancro (AIRC and FIRC), Italy and from EC RISC-RAD project.

Author information

Authors and Affiliations

  1. Department of Experimental Oncology and Laboratories, Istituto Nazionale Tumori, Milan, Italy

    R Gianni-Barrera, M Gariboldi, L De Cecco, G Manenti & T A Dragani

  2. IFOM Foundation, Milan, Italy

    M Gariboldi & L De Cecco

Authors
  1. R Gianni-Barrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Gariboldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L De Cecco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Manenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T A Dragani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T A Dragani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gianni-Barrera, R., Gariboldi, M., De Cecco, L. et al. Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells. Oncogene 25, 4501–4504 (2006). https://doi.org/10.1038/sj.onc.1209478

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209478

Keywords

This article is cited by

Search

Advanced search

Quick links